Neureva Pharma develops innovative therapeutics to repair the Spinal Cord

Our strong scientific and technical expertise together with our sophisticated vitro/vivo screening platform allow us to finely tune both the anti-excitotoxic or pro-regenerating characteristics of the molecules of our pipeline.

We develop small molecules for enhancing chronic regeneration, initiating hyper-acute and acute neuroprotection and treating post-traumatic neuropathic pain.

OUR WEBSITE IS UNDER CONSTRUCTION .....